Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos
- Address
- lock Available on a paid plan
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos (Lithuanian University of Health Sciences Hospital Kauno Klinikos) is a leading academic medical center engaged in advanced oncology research and treatment. The institution specializes in early-phase clinical trials investigating novel therapeutic approaches for complex cancer conditions.
- KRAS-mutant solid tumor research and targeted therapy development
- Lung cancer clinical investigation and treatment innovation
- Phase 1 oncology studies for advanced solid malignancies
The center's research portfolio demonstrates expertise in precision oncology, particularly focusing on KRAS mutations and their therapeutic targeting in advanced solid tumors. As part of Lithuania's premier academic health system, Kauno Klinikos contributes to international collaborative efforts in developing cutting-edge cancer treatments for patients with difficult-to-treat malignancies.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Merck Sharp & Dohme LLC1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 1 Evaluation of MK-1084 in Patients with KRAS Mutant Advanced Solid Tumors, Including Lung Cancer | Merck Sharp & Dohme LLC | Phase I | Recruiting | Dec 2021 | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.